Robert Osburne is an Endocrinology/Metabolic physician affiliated with University of Alabama. OpenAlex indexes 20 publications with 535 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
850 Peter Bryce Blvd
Tuscaloosa, AL 354017457
Telephone
205-873-2699Registry record last updated 26 Oct 2018.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
72.4%Insulin Analog37.7%Lantus Solostar28%Tresiba Flextouch U-10018%Novolog Flexpen15%Toujeo Max Solostar13%Tresiba Flextouch U-20012%Fiasp9%Humalog Kwikpen U-1006%Part D<11 patientsGLP-1 receptor agonist20.6%Ozempic43%Trulicity36%Rybelsus21%Part D<11 patients+ 3 more classes in this area
Hormonal (systemic)
15%l-Thyroxine6.5%Levothyroxine Sodium100%Part D<11 patientsThyroid Hormone Synthesis Inhibitor5.5%Methimazole100%Part D≥11 patients+ 1 more class in this area
Cardiovascular
10.3%Statin6.7%Rosuvastatin Calcium68%Atorvastatin Calcium32%Part D<11 patientsCalcium channel blocker3.6%Amlodipine Besylate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Oral Nanocurcumin Alone or in Combination with Insulin Alleviates STZ-Induced Diabetic Neuropathy in Rats
Molecular Pharmaceutics
2022 - Perceptions of resident physicians about management of inpatient hyperglycemia in an urban hospital
Journal of Hospital Medicine
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Feig, MD, PhD
University of Alabama
Jeffrey Roseman, MD
University of Alabama
Gilbert Perry
University of Alabama
Eroboghene Ubogu, MD
University of Alabama
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”